By Popular Demand: Growth Capital Expo Day Two to Feature Expert Panel and Presentations by Top Marijuana-Related Companies
April 14 2014 - 8:00AM
Marketwired
By Popular Demand: Growth Capital Expo Day Two to Feature Expert
Panel and Presentations by Top Marijuana-Related Companies
LAS VEGAS, NV--(Marketwired - Apr 14, 2014) - An expanded
discussion of the prospects and trends in investment in legal
marijuana-related businesses, plus presentations by publicly traded
and pre-IPO cannabis-related companies, will be featured on the
second day program on May 1 at The Growth Capital Expo 2014, at the
Caesars Palace conference center in Las Vegas, NV.
Day Two of the Expo will feature an expert panel of marijuana
investors, medical practitioners and entrepreneurs to address the
near and mid-term prospects for legal marijuana-related business
models and sectors -- including current and emerging opportunities
in pharmaceuticals, botanicals, business services and consumer
goods. The panel will be moderated by Troy Dayton, founder of The
ArcView Group, the first angel group dedicated to legal
marijuana-related investment.
Joining Mr. Dayton is:
- Justin Hartfield, The Ghost Group. Co-founder of WeedMaps.com,
the first publicly traded marijuana-related company to surpass $15
million in annual sales, now an investor in marijuana-related
startups. Board member of the National Cannabis Industry
Association, the Marijuana Policy Project, and the National
Organization for the Reform of Marijuana Laws.
- Dr. Lawrence May, Tauriga Sciences. Member of Medical Advisory
Board at Tauriga Sciences (OTCQB: TAUG), a publicly traded life
science holding company that is focused on proprietary
biotherapeutics and diagnostics using cannabis-derived compounds.
Former executive vice president for medical and scientific affairs
for Herbalife International; on the clinical faculty of the UCLA
medical school.
- Doug Leighton, Dutchess Capital. Co-founder and principal of
Dutchess Capital, a micro-cap focused hedge fund with more than $2
billion in transactional value over a decade of investing. Now a
member of the investment committee at ArcView Group, and an active
investor and board member for several marijuana-related
companies.
- Dr. Mark L. Rabe, Medical Marijuana Sciences. Dr. Rabe is
Chairman of the Scientific Advisory Board of Medical Marijuana
Sciences, a subsidiary of Nuvilex, Inc. (OTCQB: NVLX), an
international biotechnology company providing cell and gene therapy
solutions for the treatment of diseases. Dr. Rabe is the former
Chief Medical Officer of the largest group of physician-owned
alternative medicine clinics in California.
- Khurshid Khoja, Greenbridge Corporate Counsel. In addition to
leading the Cannabis & Hemp Industry practice at Greenbridge,
Khurshid currently serves on the Board of Directors of the
California Cannabis Industry Association and the Illinois Cannabis
Industry Association. Prior to founding Greenbridge, Khurshid
practiced corporate and transactional law at Thelen LLP and Reed
Smith LLP.
The 60-minute panel, titled "By Popular Demand: Opportunities
For Institutional Investment In Marijuana-Related Companies," will
highlight a of full day of marijuana investment programming,
including investor presentations by the chief executives of six
publicly traded companies pursuing medical marijuana and
cannabis-related strategies, including Nuvilex (OTCQB: NVLX),
Tauriga Sciences, MedBox (OTCQB: MDBX), Advanced Cannabis
Solutions, Endexx (PINKSHEETS: EDXC) and BreedIT (OTCQB: BRDT).
More information on the presenting companies is available on the
Expo website,
http://growthcapitalexpo.com/presenting-companies/.
"Day Two of this year's Growth Capital Expo is devoted entirely
to the innovations in the capital markets resulting from the
democratization of capital investment embodied in the JOBS Act,"
said Brett Goetschius, Editor and Publisher of Growth Capital
Investor, and co-host of the Expo. "It's where Wall Street
meets Crowd Street. And I can think of no better example where the
sentiment of the crowd is driving markets harder and faster than in
the area of marijuana-related goods and services. The people are
speaking, with their actions, their votes and their dollars.
Investors ignore them at their peril."
To make the "By Popular Demand" panel available to the widest
possible audience, special reduced-price Day Two-only tickets are
available online at the Expo website. The single-day ticket offers
complete access to the full day of Expo programs and presentations
on crowdsourced capital and investment, including the full schedule
of presentations by over 50 public and private emerging growth
companies. To purchase the special Day Two ticket, go to
http://growthcapitalexpo.com/register.
Forward-Looking Statements This news release may include certain
forward-looking statements. All statements, other than statements
of historical fact, included in this release are forward-looking
statements that involve various risks and uncertainties. There can
be no assurance that such statements will prove to be accurate and
actual results and future events could differ materially from those
anticipated in such statements. This notice expressly qualifies all
forward-looking statements in this release. The Company, through
its management, makes forward-looking public statements concerning
its expected future operations, performance and other developments.
Such forward-looking statements are necessary estimates reflecting
the Company's best judgment based upon current information and
involve a number of risks and uncertainties, and there can be no
assurance that other factors will not affect the accuracy of such
forward-looking statements. It is impossible to identify all such
factors, factors that could cause actual results to differ
materially from those estimated by the Company. They include, but
are not limited to, government regulation, managing and maintaining
growth, the effect of adverse publicity, litigation, competition
and other factors, which may be identified, from time to time in
the Company's public announcements.
Contact: Robert Kraft Email Contact